The STanding Orders Protocol (STOP): A Pharmacy Driven Pneumococcal and Influenza Vaccination Program

Veltri, Keith T.; Ferguson-Myrthil, Nadia; Currie, Brian
October 2009
Hospital Pharmacy;Oct2009, Vol. 44 Issue 10, p874
Academic Journal
Purpose: A Medical Board-approved pharmacy-based inpatient STanding Orders Protocol (STOP) for influenza and pneumococcal vaccination was designed and implemented at Montefiore Medical Center in response to federal and state regulations put in place in 2006. This vaccination program aims to improve historically poor vaccination rates in a complex, urban patient population. Developing this initiative in a large health care system with high turnover and a diverse (many non-English speaking) population represented a formidable challenge. Methods: In 2006 the institution initiated a program to improve patient care. The program involved a clinical pharmacist rounding on patient care units specifically to encourage the acceptance of the pneumococcal and influenza vaccine in patients at least 65 years of age at 1 of the 2 campus sites in the Bronx, New York. Medical residents were also employed to facilitate the pharmacist and achieve national standards. Registered nurses and licensed practical nurses are authorized to administer standing orders for vaccines and anaphylaxis treatment agents as needed under this protocol without direct physician examination. Vaccine information sheets (VIS) and gender- and ethnicity-specific patient teaching aids provide statistical information regarding disease and mortality rates. Language barriers are reduced by providing VIS in both Spanish and English, and telephone translation in most languages are utilized when necessary. Documentation of refusal of, previously received, or a newly ordered vaccination is placed in the patient's chart and in the central database. Discussion: Prior to the STOP program, the total in-hospital vaccination encounter rates according to various Center for Medicare and Medicaid Services (CMS) audits was approximately 18% for pneumococcal and 27% for influenza vaccinations, respectively. The institution's current encounter rates have dramatically increased to more than 85% for pneumococcal and 55% for influenza vaccine. Conclusion: The cooperative efforts of physicians, pharmacists, and nursing staff have led to the creation of a successful inpatient-based vaccine standing orders protocol. As a result, in 2007 the institution approved a second clinical pharmacist to allow for coverage at both of Montefiore's hospital sites. The hospital's goal is to ultimately decrease pneumococcal disease and its severity, increase and maintain the highest vaccination rates in New York City, and comply with national standards. The implication for decreasing morbidity and readmission of patients is promising. Future plans include the development of an ambulatory-based program with a similar design model.


Related Articles

  • Elderly flu, pneumococcal vaccination rates reach highest levels yet.  // Geriatrics;Mar97, Vol. 52 Issue 3, p75 

    Presents an abstract of the article `Pneumococcal and Influenza Vaccination Levels Among Adults Aged >- 65 Years,' published in `MMWR' dated 1996.

  • Simultaneous administration of influenza, pneumococcal vaccines recommended.  // Brown University Long-Term Care Quality Advisor;5/13/96, Vol. 8 Issue 9, p6 

    Focuses on the results of a study in Finland on the reactions associated with the simultaneous administration of pneumococcal and influenza vaccines. Estimated of pneumococcal vaccines compared to influenza vaccines in the United States; Number of patients studied; Scale used to record the...

  • Influenza and pneumococcal vaccines: Hand-in-glove?  // Patient Care;3/15/1996, Vol. 30 Issue 5, p200 

    Reports that only 40 percent and 10 percent of elderly patients get the influenza and pneumococcal vaccines each year despite the officials recommendations that all people older than 65 receive both vaccines. Finnish researchers theories; How vaccines can and should be administered.

  • BY THE NUMBERS.  // Infectious Diseases in Children;Feb2014, Vol. 27 Issue 2, p1 

    A chart is presented that compares data on trivalent inactivated influenza vaccine (TIV) and pneumococcal conjugate vaccine Prevnar 13 (PCV 13) that were given to children with fever during the same visit versus separately.

  • Reasons Reported by Medicare Beneficiaries for Not Receiving Influenza and Pneumococcal ...  // MMWR: Morbidity & Mortality Weekly Report;10/8/1999, Vol. 48 Issue 39, p886 

    Details several reasons Medicare beneficiaries in the United States failed to receive influenza and pneumococcal vaccinations in 1996. Analysis on the 1996 Medicare Current Beneficiary Survey.

  • Vaccination rates among the elderly are improving.  // Modern Medicine;Jan99, Vol. 67 Issue 1, p12 

    Discusses the abstract `Influenza and Pneumococcal Vaccination Levels Among Adults Aged ...65 Years--United States?' by the Centers for Disease Control.

  • Pneumococcal campaign should be on same scale as flu, say experts. Bhattacharya, Shaoni // Pulse;7/8/2002, Vol. 62 Issue 27, p8 

    Reports that immunization experts are calling for a pneumococcal vaccination on the scale of flu vaccination campaign in Great Britain. Result of a study on pneumococcal vaccine uptake; Reason residents in nursing homes in Scotland have not received the vaccine; Coverage rates for flu and...

  • Use of Standing Orders Programs to Increase Adult Vaccination Rates.  // MMWR: Morbidity & Mortality Weekly Report;3/25/2000, Vol. 49 Issue 11, p21 

    Looks at the evidence regarding the effectiveness of standing orders programs in improving adult vaccination coverage rates and recommends prioritizing programs for influenza and pneumococcal vaccinations. Information on the epidemics of influenza and the pneumococcal vaccines; Implementation...

  • Influenza and pneumococcal vaccination coverage levels among persons aged ...65 years--United...  // MMWR: Morbidity & Mortality Weekly Report;7/14/1995, Vol. 44 Issue 27, p506 

    Summarizes estimates of influenza and pneumococcal vaccination coverage levels among persons aged above 65 years during 1973-1993 based on data from the United States Immunization Survey and from the National Health Interview Survey. Reduction of high morbidity and mortality associated with...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics